首页 > 最新文献

International journal of pediatric otorhinolaryngology最新文献

英文 中文
The AMSA® manosonic nebulizer for ENT disease among children in Poland 用于治疗波兰儿童耳鼻喉疾病的 AMSA® manosonic 雾化吸入器
IF 1.2 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-09-20 DOI: 10.1016/j.ijporl.2024.112113
<div><h3>Introduction</h3><div>The AMSA® manosonic nebulizer uses acoustic vibration and a flow of air to create an aerosol from a solution or suspension of a drug. The aerosol created this way is claimed to have enhanced penetration and drug delivery. It is administered under short-term overpressure, meaning that the aerosol is able to penetrate into the middle ear through the Eustachian tube (ET).</div></div><div><h3>Purpose</h3><div>of the study: The aim of this study is to identify the active substances used in AMSA® manosonic nebulization for treating common ENT diseases in children aged 2–17 years and to evaluate the overall effectiveness of AMSA® manosonic nebulization in this context. Assessments were done by comparing conditions before and after nebulization using the following tests: (1) Eustachian tube function test, (2) tympanometry, and (3) otoscopy.</div></div><div><h3>Material and methods</h3><div>This study was a retrospective study with ethics committee consent. 129 children, comprising 56 girls and 73 boys. They were aged between 2 and 17 years, with a mean age of 6.9 years (SD = 3.0). There were 74 children up to 6 years and 55 children over 6 years of age. Children had the following conditions: (1) chronic otitis media with effusion, OME (n = 86), (2) Eustachian tube dysfunction, ETD (n = 34) (3) Other conditions (e.g. cholesteatoma, retraction pocket), (n = 9). Combination of medicines administered in this study was: Budesonide + ambroxol (with or without NaCl), Budesonide (with or without NaCl), Budesonide + N-acetylcysteine (with or without NaCl), Budesonide + hyaluronic acid, Budesonide + ambroxol (with hyaluronic acid), Ambroxol (with or without NaCl).</div></div><div><h3>Results</h3><div>The number of nebulizations ordered was between 1 and 20 treatments, but most commonly, pa-tients were given a nebulization series of 10 treatments. This was the case for 80.6 % of the patients. Most patients with OME and ETD had 10 treatments ordered (79 % and 79.5 %, respectively), while all patients with other conditions had 10 treatments. Analysis of the tympanometry results was done in terms of the number of affected ears (not by individual). There were 210 ears with complete tympanometry (both pre and post), including 142 ears with OME, 54 with ETD, and 14 others. Statistically significant changes (improvements) after AMSA nebulizations were found for statistic compliance and middle ear pressure. Otoscopy assessments were done in all ears. The results were abnormal in 155 ears (73.8 %) and normal in 55 ears (26.2 %). After AMSA nebulizations, the number of abnormal results decreased to 117 ears (55.7 %) and normal results were found in 93 ears (44.7 %).</div></div><div><h3>Conclusion</h3><div>Use of the AMSA manosonic nebulizer appears to be an effective way of improving chronic medical conditions in children – such as chronic otitis media with effusion and Eustachian tube defect – but only if patient compliance can be achieved. Th
简介 AMSA® manosonic 雾化器利用声波振动和气流将药物溶液或悬浮液制成气溶胶。据称,以这种方式产生的气溶胶具有更强的渗透性和给药性。它是在短期超压的情况下给药的,这意味着气雾剂能够通过咽鼓管(ET)渗入中耳:本研究旨在确定 AMSA® manosonic 雾化疗法中用于治疗 2-17 岁儿童常见耳鼻喉疾病的活性物质,并评估 AMSA® manosonic 雾化疗法在这方面的总体效果。通过比较雾化前后的情况,使用以下测试进行评估:(1) 咽鼓管功能测试;(2) 鼓室测量法;(3) 耳镜检查。129 名儿童中包括 56 名女孩和 73 名男孩。他们的年龄在 2 到 17 岁之间,平均年龄为 6.9 岁(SD = 3.0)。其中 6 岁以下儿童 74 名,6 岁以上儿童 55 名。儿童患有以下疾病:(1)慢性中耳炎伴流脓(OME,n = 86);(2)咽鼓管功能障碍(ETD,n = 34);(3)其他疾病(如胆脂瘤、回缩袋)(n = 9)。本研究中的联合用药为布地奈德+氨溴索(含或不含氯化钠)、布地奈德(含或不含氯化钠)、布地奈德+N-乙酰半胱氨酸(含或不含氯化钠)、布地奈德+透明质酸、布地奈德+氨溴索(含透明质酸)、氨溴索(含或不含氯化钠)。80.6%的患者都是这种情况。大多数 OME 和 ETD 患者都接受了 10 次治疗(分别为 79% 和 79.5%),而所有其他疾病患者都接受了 10 次治疗。对鼓室测量结果的分析是按受影响耳朵的数量进行的(而不是按个人)。共有 210 只耳朵进行了完整的鼓室测量(包括治疗前和治疗后),其中包括 142 只患有 OME 的耳朵、54 只患有 ETD 的耳朵和 14 只其他耳朵。经AMSA雾化治疗后,统计顺应性和中耳压力均有明显改善。对所有耳朵进行了耳镜检查。结果显示,155 只耳朵(73.8%)异常,55 只耳朵(26.2%)正常。结论使用 AMSA 人工渗液雾化器似乎是改善儿童慢性疾病(如慢性中耳炎伴渗液和咽鼓管缺损)的有效方法,但前提是患者必须遵从医嘱。最常用的活性物质是布地奈德,与是否使用额外的分泌物/褐质溶解剂无关。
{"title":"The AMSA® manosonic nebulizer for ENT disease among children in Poland","authors":"","doi":"10.1016/j.ijporl.2024.112113","DOIUrl":"10.1016/j.ijporl.2024.112113","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Introduction&lt;/h3&gt;&lt;div&gt;The AMSA® manosonic nebulizer uses acoustic vibration and a flow of air to create an aerosol from a solution or suspension of a drug. The aerosol created this way is claimed to have enhanced penetration and drug delivery. It is administered under short-term overpressure, meaning that the aerosol is able to penetrate into the middle ear through the Eustachian tube (ET).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Purpose&lt;/h3&gt;&lt;div&gt;of the study: The aim of this study is to identify the active substances used in AMSA® manosonic nebulization for treating common ENT diseases in children aged 2–17 years and to evaluate the overall effectiveness of AMSA® manosonic nebulization in this context. Assessments were done by comparing conditions before and after nebulization using the following tests: (1) Eustachian tube function test, (2) tympanometry, and (3) otoscopy.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Material and methods&lt;/h3&gt;&lt;div&gt;This study was a retrospective study with ethics committee consent. 129 children, comprising 56 girls and 73 boys. They were aged between 2 and 17 years, with a mean age of 6.9 years (SD = 3.0). There were 74 children up to 6 years and 55 children over 6 years of age. Children had the following conditions: (1) chronic otitis media with effusion, OME (n = 86), (2) Eustachian tube dysfunction, ETD (n = 34) (3) Other conditions (e.g. cholesteatoma, retraction pocket), (n = 9). Combination of medicines administered in this study was: Budesonide + ambroxol (with or without NaCl), Budesonide (with or without NaCl), Budesonide + N-acetylcysteine (with or without NaCl), Budesonide + hyaluronic acid, Budesonide + ambroxol (with hyaluronic acid), Ambroxol (with or without NaCl).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;The number of nebulizations ordered was between 1 and 20 treatments, but most commonly, pa-tients were given a nebulization series of 10 treatments. This was the case for 80.6 % of the patients. Most patients with OME and ETD had 10 treatments ordered (79 % and 79.5 %, respectively), while all patients with other conditions had 10 treatments. Analysis of the tympanometry results was done in terms of the number of affected ears (not by individual). There were 210 ears with complete tympanometry (both pre and post), including 142 ears with OME, 54 with ETD, and 14 others. Statistically significant changes (improvements) after AMSA nebulizations were found for statistic compliance and middle ear pressure. Otoscopy assessments were done in all ears. The results were abnormal in 155 ears (73.8 %) and normal in 55 ears (26.2 %). After AMSA nebulizations, the number of abnormal results decreased to 117 ears (55.7 %) and normal results were found in 93 ears (44.7 %).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;Use of the AMSA manosonic nebulizer appears to be an effective way of improving chronic medical conditions in children – such as chronic otitis media with effusion and Eustachian tube defect – but only if patient compliance can be achieved. Th","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142319883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dysphagia is a strong predictor of revision supraglottoplasty in pediatric laryngomalacia 吞咽困难是预测小儿喉头畸形喉上成形术翻修的一个重要因素
IF 1.2 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-09-17 DOI: 10.1016/j.ijporl.2024.112115

Background

There is growing research on the association between swallowing dysfunction and laryngomalacia. Supraglottoplasty is the surgical intervention used to treat laryngomalacia, however a portion of patients who undergo this procedure will require a revision surgery. Predictive risk factors for revision supraglottoplasty in patients with laryngomalacia are not well understood, and previous studies failed to evaluate swallowing systematically.

Hypothesis

We predict a significant association between swallowing dysfunction and revision supraglottoplasty for patients with laryngomalacia.

Methods

This was a retrospective cohort study of consecutive patients between 2013 and 2023 at a tertiary pediatric care centre (Stollery Children's Hospital). All patients had an endoscopic diagnosis of laryngomalacia by a staff otolaryngologist and at minimum a systematic clinical swallowing assessment by a speech language pathologist, with an instrumental assessment as needed. Patients with genetic or neurological comorbidities, lack of follow up information, or age of >3 years were excluded. Clinical and instrumental swallow data, demographic information, surgical outcomes and revision surgeries were documented and collected. Univariate analysis was done to determine associations between variables and revision supraglottoplasty. Binary logistic regression was done to determine independent predictors of revision supraglottoplasty.

Results

214 patients met the inclusion criteria and were analyzed in the study. 24 patients (11 %) required revision supraglottoplasty. 118 out of the 214 patients (55 %) had an instrumental assessment completed (FEES or VFSS). Of those, 92 (78 %) had abnormal findings on instrumental assessments. Univariate analysis showed Type 2 laryngomalacia (P = 0.017), presence of aspiration (P=<0.001), presence of cyanosis (P = 0.002) and abnormal findings on an instrumental assessment (P = 0.013) to be significantly associated with the need for revision supraglottoplasty. Binary regression analysis showed aspiration (OR = 5.6 {2.087–14.889}, P=<0.001) and cyanosis (OR = 5.3 {1.852–15.181}, P = 0.002) to be the only independent predictors of revision supraglottoplasty.

Conclusion

Presence of aspiration is a strong predictive factor for revision supraglottoplasty in patients with laryngomalacia, when swallowing is evaluated systematically. More prospective research is needed to understand the relationship between swallowing dysfunction, laryngomalacia and surgery.

背景关于吞咽功能障碍与喉水肿之间关系的研究越来越多。声门上成形术是用于治疗喉肌无力的手术干预措施,但部分接受过该手术的患者需要进行翻修手术。我们预测吞咽功能障碍与喉上成形术翻修之间存在显著关联。方法这是一项回顾性队列研究,研究对象为一家三级儿科医疗中心(斯托莱里儿童医院)2013年至2023年间的连续患者。所有患者均经耳鼻喉科医生内镜诊断为喉发育不全,并至少由言语病理学家进行了系统的临床吞咽评估,必要时还进行了仪器评估。有遗传或神经系统合并症、缺乏随访信息或年龄小于 3 岁的患者被排除在外。记录并收集了临床和仪器吞咽数据、人口统计学信息、手术结果和翻修手术。通过单变量分析确定变量与翻修声门上成形术之间的关联。结果214名患者符合纳入标准,并在研究中进行了分析。24名患者(11%)需要进行翻修声门上成形术。214 名患者中有 118 名(55%)完成了仪器评估(FEES 或 VFSS)。其中 92 人(78%)的器械评估结果异常。单变量分析显示,2 型喉瘤(P = 0.017)、吸入(P=0.001)、发绀(P = 0.002)和器械评估结果异常(P = 0.013)与翻修声门上成形术的需求显著相关。二元回归分析显示,吸入(OR = 5.6 {2.087-14.889}, P=<0.001)和发绀(OR = 5.3 {1.852-15.181}, P=0.002)是唯一可预测喉上成形术翻修的独立因素。需要进行更多的前瞻性研究,以了解吞咽功能障碍、喉气肿和手术之间的关系。
{"title":"Dysphagia is a strong predictor of revision supraglottoplasty in pediatric laryngomalacia","authors":"","doi":"10.1016/j.ijporl.2024.112115","DOIUrl":"10.1016/j.ijporl.2024.112115","url":null,"abstract":"<div><h3>Background</h3><p>There is growing research on the association between swallowing dysfunction and laryngomalacia. Supraglottoplasty is the surgical intervention used to treat laryngomalacia, however a portion of patients who undergo this procedure will require a revision surgery. Predictive risk factors for revision supraglottoplasty in patients with laryngomalacia are not well understood, and previous studies failed to evaluate swallowing systematically.</p></div><div><h3>Hypothesis</h3><p>We predict a significant association between swallowing dysfunction and revision supraglottoplasty for patients with laryngomalacia.</p></div><div><h3>Methods</h3><p>This was a retrospective cohort study of consecutive patients between 2013 and 2023 at a tertiary pediatric care centre (Stollery Children's Hospital). All patients had an endoscopic diagnosis of laryngomalacia by a staff otolaryngologist and at minimum a systematic clinical swallowing assessment by a speech language pathologist, with an instrumental assessment as needed. Patients with genetic or neurological comorbidities, lack of follow up information, or age of &gt;3 years were excluded. Clinical and instrumental swallow data, demographic information, surgical outcomes and revision surgeries were documented and collected. Univariate analysis was done to determine associations between variables and revision supraglottoplasty. Binary logistic regression was done to determine independent predictors of revision supraglottoplasty.</p></div><div><h3>Results</h3><p>214 patients met the inclusion criteria and were analyzed in the study. 24 patients (11 %) required revision supraglottoplasty. 118 out of the 214 patients (55 %) had an instrumental assessment completed (FEES or VFSS). Of those, 92 (78 %) had abnormal findings on instrumental assessments. Univariate analysis showed Type 2 laryngomalacia (P = 0.017), presence of aspiration (P=&lt;0.001), presence of cyanosis (P = 0.002) and abnormal findings on an instrumental assessment (P = 0.013) to be significantly associated with the need for revision supraglottoplasty. Binary regression analysis showed aspiration (OR = 5.6 {2.087–14.889}, P=&lt;0.001) and cyanosis (OR = 5.3 {1.852–15.181}, P = 0.002) to be the only independent predictors of revision supraglottoplasty.</p></div><div><h3>Conclusion</h3><p>Presence of aspiration is a strong predictive factor for revision supraglottoplasty in patients with laryngomalacia, when swallowing is evaluated systematically. More prospective research is needed to understand the relationship between swallowing dysfunction, laryngomalacia and surgery.</p></div>","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0165587624002696/pdfft?md5=c5694037aea7c67be7a9f896b9cb098b&pid=1-s2.0-S0165587624002696-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142239908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does injection of botulinum toxin to salivary glands require ultrasound guidance? 唾液腺肉毒素注射是否需要超声引导?
IF 1.2 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-09-17 DOI: 10.1016/j.ijporl.2024.112114

Introduction

Injection of botulinum toxin into salivary glands is a well-established treatment for sialorrhea in children, but the absolute need for radiological guidance has not been tested.

Methods

Single-centre study in which clinicians of varying seniority attempted blind injection of salivary glands, after which their position within or outside the gland was confirmed by ultrasound guidance before the injection is administered.

Results

117 patients underwent botulinum toxin of salivary glands between November 2008 and August 2023, with 459 glands injected in total. 24 (5 %) glands were injected by medical students, 32 (7 %) by junior trainees (foundation doctors or senior house officers), 343 (75 %) by registrars or senior fellows and 36 (8 %) by consultants. 160 (68 %) of injections to the parotid gland were on target, and 74 (32 %) submandibular gland were on target (P < 0.01). No differences were detected on likelihood of success depending on seniority of practitioner, age of patient or hand dominance.

Conclusion

Ultrasound guidance ought to be recommended for injection of botulinum toxin into salivary glands regardless of the seniority of the practitioner.
方法在单中心研究中,不同资历的临床医生尝试对唾液腺进行盲注,之后在注射前通过超声引导确认其在腺体内或外的位置。结果2008年11月至2023年8月期间,117名患者接受了唾液腺肉毒素注射,共注射了459个腺体。其中 24 个(5%)腺体由医学生注射,32 个(7%)由初级受训人员(基础医生或高级住院医师)注射,343 个(75%)由注册医师或高级研究员注射,36 个(8%)由顾问注射。腮腺注射中有 160 次(68%)达到目标,颌下腺注射中有 74 次(32%)达到目标(P < 0.01)。结论:在唾液腺注射肉毒杆菌毒素时,无论医生的资历如何,都应推荐使用超声波引导。
{"title":"Does injection of botulinum toxin to salivary glands require ultrasound guidance?","authors":"","doi":"10.1016/j.ijporl.2024.112114","DOIUrl":"10.1016/j.ijporl.2024.112114","url":null,"abstract":"<div><h3>Introduction</h3><div>Injection of botulinum toxin into salivary glands is a well-established treatment for sialorrhea in children, but the absolute need for radiological guidance has not been tested.</div></div><div><h3>Methods</h3><div>Single-centre study in which clinicians of varying seniority attempted blind injection of salivary glands, after which their position within or outside the gland was confirmed by ultrasound guidance before the injection is administered.</div></div><div><h3>Results</h3><div>117 patients underwent botulinum toxin of salivary glands between November 2008 and August 2023, with 459 glands injected in total. 24 (5 %) glands were injected by medical students, 32 (7 %) by junior trainees (foundation doctors or senior house officers), 343 (75 %) by registrars or senior fellows and 36 (8 %) by consultants. 160 (68 %) of injections to the parotid gland were on target, and 74 (32 %) submandibular gland were on target (P &lt; 0.01). No differences were detected on likelihood of success depending on seniority of practitioner, age of patient or hand dominance.</div></div><div><h3>Conclusion</h3><div>Ultrasound guidance ought to be recommended for injection of botulinum toxin into salivary glands regardless of the seniority of the practitioner.</div></div>","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of concha bullosa in a pediatric population 儿科牛皮癣的发病率
IF 1.2 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-09-13 DOI: 10.1016/j.ijporl.2024.112108

Objective

Existing literature on the prevalence of middle turbinate pneumatization, or concha bullosa (CB), in the pediatric population is limited. CB is an anatomic variant important to identify prior to sinonasal surgery and is often associated with congenital nasal septal deviation (SD). This paper aims to describe the prevalence of CB in the pediatric population on head imaging.

Methods

A retrospective chart review was performed for 695 children undergoing CT head for trauma from 2021 to 2022. Nearly equal numbers of males and females were evaluated, with at least 19–20 per year from 0.5 to 18 years. Patients with significant facial fractures, sinusitis, craniofacial syndromes, prior sinus surgery, and sinonasal masses were excluded. Two pediatric neuroradiologists evaluated the CTs. CB was defined as aeration >50 % of the vertical height of the middle turbinate.

Results

In this study, 384 patients were included. The prevalence of CB was 153 (39.8 %), which was significantly higher in children >4 years (p < 0.0001). Lamellar type CB was the most common, present in 160 out of 768 middle turbinates assessed (20.8 %). SD occurred in 60 (39.2 %) patients with CB and was more commonly contralateral to the CB.

Conclusions

The prevalence of CB in the pediatric population is at the lower range of what is reported in the adult literature. The most common type of CB in patients is lamellar. Similar to previous studies, there is an association between CB and contralateral SD. Finally, there is a positive correlation between the severity of CB and the severity of SD.

目的有关中鼻甲气化或牛皮癣(CB)在儿科人群中发病率的现有文献很有限。中鼻甲积气是鼻窦手术前需要鉴别的一种解剖变异,通常与先天性鼻中隔偏曲(SD)有关。本文旨在描述 CB 在儿童头部成像中的患病率。方法对 2021 年至 2022 年期间因外伤接受头部 CT 检查的 695 名儿童进行了回顾性病历审查。接受评估的男性和女性人数几乎相等,从0.5岁到18岁,每年至少有19-20名儿童接受评估。有明显面部骨折、鼻窦炎、颅面综合征、曾接受鼻窦手术和鼻窦肿块的患者被排除在外。两名儿科神经放射专家对 CT 进行了评估。CB定义为中鼻甲垂直高度的50%。CB的发病率为153例(39.8%),4岁儿童的发病率明显更高(p <0.0001)。瓣膜型 CB 最常见,在评估的 768 个中鼻甲中有 160 个(20.8%)。60名(39.2%)CB 患者出现 SD,且多发生在 CB 的对侧。患者中最常见的 CB 类型是片状。与之前的研究相似,CB 与对侧 SD 存在关联。最后,CB 的严重程度与 SD 的严重程度呈正相关。
{"title":"Prevalence of concha bullosa in a pediatric population","authors":"","doi":"10.1016/j.ijporl.2024.112108","DOIUrl":"10.1016/j.ijporl.2024.112108","url":null,"abstract":"<div><h3>Objective</h3><p>Existing literature on the prevalence of middle turbinate pneumatization, or concha bullosa (CB), in the pediatric population is limited. CB is an anatomic variant important to identify prior to sinonasal surgery and is often associated with congenital nasal septal deviation (SD). This paper aims to describe the prevalence of CB in the pediatric population on head imaging.</p></div><div><h3>Methods</h3><p>A retrospective chart review was performed for 695 children undergoing CT head for trauma from 2021 to 2022. Nearly equal numbers of males and females were evaluated, with at least 19–20 per year from 0.5 to 18 years. Patients with significant facial fractures, sinusitis, craniofacial syndromes, prior sinus surgery, and sinonasal masses were excluded. Two pediatric neuroradiologists evaluated the CTs. CB was defined as aeration &gt;50 % of the vertical height of the middle turbinate.</p></div><div><h3>Results</h3><p>In this study, 384 patients were included. The prevalence of CB was 153 (39.8 %), which was significantly higher in children &gt;4 years (p &lt; 0.0001). Lamellar type CB was the most common, present in 160 out of 768 middle turbinates assessed (20.8 %). SD occurred in 60 (39.2 %) patients with CB and was more commonly contralateral to the CB.</p></div><div><h3>Conclusions</h3><p>The prevalence of CB in the pediatric population is at the lower range of what is reported in the adult literature. The most common type of CB in patients is lamellar. Similar to previous studies, there is an association between CB and contralateral SD. Finally, there is a positive correlation between the severity of CB and the severity of SD.</p></div>","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142233834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Holiday letter 2024. 2024 年假日信。
IF 1.2 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-09-13 DOI: 10.1016/j.ijporl.2024.112098
Joseph E Kerschner
{"title":"Holiday letter 2024.","authors":"Joseph E Kerschner","doi":"10.1016/j.ijporl.2024.112098","DOIUrl":"https://doi.org/10.1016/j.ijporl.2024.112098","url":null,"abstract":"","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142287273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
International perspective of injection laryngoplasty for laryngeal cleft – A survey study 喉裂注射成形术的国际视角 - 一项调查研究
IF 1.2 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-09-10 DOI: 10.1016/j.ijporl.2024.112097

Objectives

Laryngeal Cleft (LC) is an anatomical defect that can cause swallowing difficulties and subsequent recurrent respiratory symptoms. LC can be treated surgically by performing suture repair or by Injection Laryngoplasty (IL). The indications and efficacy of IL are debated among pediatric otolaryngologists. The aim of this survey study was to review the international perspective on IL for LC.

Methods

An online survey was conducted to assess international opinions on the indications and efficacy of IL for LC patients. An online survey was sent to 250 pediatric otolaryngologists worldwide. The survey included questions on the management of LC, the physicians’ experience with IL, and their use of IL.

Results

Sixty two (25 %) pediatric otolaryngologists, from 47 medical centers, completed the survey. Of the respondents, 38 (62 %) perform IL. The most reported indication was as a diagnostic tool. For the respondents who did not perform IL, the reasons most reported were that the effect is temporary and that there is a need for a second surgery after IL.

Conclusion

According to this survey, the perspectives on the use of IL for LC differ among pediatric otolaryngologists, and there is variation in peri-and postoperative standard of care. The respondents' opinions on IL were partly dependent on the intended outcome of its use, i.e., as a permanent treatment or for other indications.

目的喉裂(LC)是一种解剖缺陷,可导致吞咽困难和随后的反复呼吸道症状。喉裂可通过缝合修复或注射喉成形术(IL)进行手术治疗。儿科耳鼻喉科医生对注射隆鼻术的适应症和疗效存在争议。本调查研究的目的是回顾国际上对IL治疗LC的看法。方法进行在线调查,评估国际上对IL治疗LC患者的适应症和疗效的看法。我们向全球 250 名儿科耳鼻喉科医生发送了在线调查问卷。结果来自 47 个医疗中心的 62 名(25%)儿科耳鼻喉科医生完成了调查。受访者中有 38 人(62%)使用 IL。报告最多的适应症是作为诊断工具。结论根据这项调查,小儿耳鼻喉科医生对在 LC 中使用 IL 的看法不尽相同,术前术后的护理标准也存在差异。受访者对IL的看法在一定程度上取决于其使用的预期结果,即作为永久性治疗还是用于其他适应症。
{"title":"International perspective of injection laryngoplasty for laryngeal cleft – A survey study","authors":"","doi":"10.1016/j.ijporl.2024.112097","DOIUrl":"10.1016/j.ijporl.2024.112097","url":null,"abstract":"<div><h3>Objectives</h3><p>Laryngeal Cleft (LC) is an anatomical defect that can cause swallowing difficulties and subsequent recurrent respiratory symptoms. LC can be treated surgically by performing suture repair or by Injection Laryngoplasty (IL). The indications and efficacy of IL are debated among pediatric otolaryngologists. The aim of this survey study was to review the international perspective on IL for LC.</p></div><div><h3>Methods</h3><p>An online survey was conducted to assess international opinions on the indications and efficacy of IL for LC patients. An online survey was sent to 250 pediatric otolaryngologists worldwide. The survey included questions on the management of LC, the physicians’ experience with IL, and their use of IL.</p></div><div><h3>Results</h3><p>Sixty two (25 %) pediatric otolaryngologists, from 47 medical centers, completed the survey. Of the respondents, 38 (62 %) perform IL. The most reported indication was as a diagnostic tool. For the respondents who did not perform IL, the reasons most reported were that the effect is temporary and that there is a need for a second surgery after IL.</p></div><div><h3>Conclusion</h3><p>According to this survey, the perspectives on the use of IL for LC differ among pediatric otolaryngologists, and there is variation in peri-and postoperative standard of care. The respondents' opinions on IL were partly dependent on the intended outcome of its use, i.e., as a permanent treatment or for other indications.</p></div>","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142164802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Annual hearing screening in children with osteogenesis imperfecta: Results from the first five years in glasgow 成骨不全症儿童的年度听力筛查:格拉斯哥头五年的结果
IF 1.2 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-09-07 DOI: 10.1016/j.ijporl.2024.112096

Background

Hearing loss is common in people with osteogenesis imperfecta (OI), although exactly how common is unknown. The prevalence of hearing loss in children with OI has been reported to be anything from 0 to 77 %. Brittle Bone Society guidelines suggest that, unless there are ear symptoms, children with OI should have their hearing tested every three years starting at age three. There is limited evidence to support this recommendation. We postulate that annual hearing screening would be easier to manage and would have a worthwhile pick-up rate.

Methods

In March 2019 we began a programme of annual hearing screening for all children (ages 0–16) with OI. We collected data on age, genotype, otoscopy findings, tympanometry findings, audiometric test results and subsequent outcomes for the first five years of our programme (2019–2024).

Results

Nineteen children with OI participated in the screening programme. Only one abnormality was found: a unilateral mild hearing impairment with a type B tympanogram, suggesting middle ear effusion. This was present in year 2 of the programme but resolved by year 3.

Conclusion

The screening programme has a low pickup rate (5 %) for new otological problems in the paediatric population. However, we believe that the low cost and small workload associated with the screening programme justifies continuing it until further conclusions can be drawn.

背景听力损失在成骨不全症(OI)患者中很常见,但具体有多常见尚不清楚。据报道,成骨不全症儿童听力损失的发生率从 0% 到 77% 不等。脆骨协会的指导方针建议,除非有耳部症状,否则患有成骨不全症的儿童应从三岁开始每三年接受一次听力测试。支持这一建议的证据有限。我们推测,每年进行一次听力筛查将更易于管理,而且筛查率也会更高。方法2019 年 3 月,我们开始对所有患有 OI 的儿童(0-16 岁)进行年度听力筛查。我们收集了该计划前五年(2019-2024 年)的年龄、基因型、耳镜检查结果、鼓室测量结果、听力测试结果和后续结果等数据。仅发现了一项异常:单侧轻度听力障碍,鼓室图为 B 型,提示中耳积液。结论:筛查计划在儿童中发现新耳科问题的比例较低(5%)。不过,我们认为,筛查项目成本低、工作量小,因此在得出进一步结论之前,有理由继续实施该项目。
{"title":"Annual hearing screening in children with osteogenesis imperfecta: Results from the first five years in glasgow","authors":"","doi":"10.1016/j.ijporl.2024.112096","DOIUrl":"10.1016/j.ijporl.2024.112096","url":null,"abstract":"<div><h3>Background</h3><p>Hearing loss is common in people with osteogenesis imperfecta (OI), although exactly how common is unknown. The prevalence of hearing loss in children with OI has been reported to be anything from 0 to 77 %. Brittle Bone Society guidelines suggest that, unless there are ear symptoms, children with OI should have their hearing tested every three years starting at age three. There is limited evidence to support this recommendation. We postulate that annual hearing screening would be easier to manage and would have a worthwhile pick-up rate.</p></div><div><h3>Methods</h3><p>In March 2019 we began a programme of annual hearing screening for all children (ages 0–16) with OI. We collected data on age, genotype, otoscopy findings, tympanometry findings, audiometric test results and subsequent outcomes for the first five years of our programme (2019–2024).</p></div><div><h3>Results</h3><p>Nineteen children with OI participated in the screening programme. Only one abnormality was found: a unilateral mild hearing impairment with a type B tympanogram, suggesting middle ear effusion. This was present in year 2 of the programme but resolved by year 3.</p></div><div><h3>Conclusion</h3><p>The screening programme has a low pickup rate (5 %) for new otological problems in the paediatric population. However, we believe that the low cost and small workload associated with the screening programme justifies continuing it until further conclusions can be drawn.</p></div>","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0165587624002507/pdfft?md5=9ab3ba5a8da76a5638b9cc24d2ab3ca8&pid=1-s2.0-S0165587624002507-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142164800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comprehensive management and classification of first branchial cleft anomalies: An International Pediatric Otolaryngology Group (IPOG) consensus statement 第一腭裂畸形的综合管理和分类:国际儿科耳鼻喉科小组(IPOG)共识声明
IF 1.2 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-09-07 DOI: 10.1016/j.ijporl.2024.112095

Objective

First branchial cleft anomalies are rare congenital head and neck lesions. Literature pertaining to classification, work up and surgical treatment of these lesions is limited and, in some instances, contradictory. The goal of this work is to provide refinement of the classification system of these lesions and to provide guidance for clinicians to aid in the comprehensive management of children with first branchial cleft anomalies.

Materials and methods

Delphi method survey of expert opinion under the direction of the International Pediatric Otolaryngology Group (IPOG) was conducted to generate recommendations for the definition and management of first branchial cleft anomalies. The recommendations are the result of expert consensus and critical review of the literature.

Results

Consensus recommendations include evaluation and diagnostic considerations for children with first branchial cleft anomalies as well as recommendations for surgical management. The current Work classification system was reviewed, and modifications were made to it to provide a more cogent categorization of these lesions.

Conclusion

The mission of the International Pediatric Otolaryngology Group (IPOG) is to develop expertise-based recommendations based on review of the literature for the management of pediatric otolaryngologic disorders. These consensus recommendations are aimed at improving care of children presenting with first branchial cleft anomalies. Here we present a revised classification system based on parotid gland involvement, with a focus on avoiding stratification based on germ layer, in addition to guidelines for management.

目的第一杈裂畸形是一种罕见的先天性头颈部病变。有关这些病变的分类、检查和手术治疗的文献十分有限,有时甚至相互矛盾。这项工作的目的是完善这些病变的分类系统,并为临床医生提供指导,以帮助对第一颅支裂畸形患儿进行综合管理。材料和方法在国际儿科耳鼻喉科小组(IPOG)的指导下,对专家意见进行了德尔菲法调查,以就第一颅支裂畸形的定义和管理提出建议。这些建议是专家们达成共识并对文献进行严格审查的结果。结果共识建议包括对第一支裂畸形患儿的评估和诊断注意事项以及手术治疗建议。结论国际儿科耳鼻喉科小组(IPOG)的使命是根据文献综述,为儿科耳鼻喉科疾病的治疗制定基于专业知识的建议。这些共识性建议旨在改善对第一杈裂畸形患儿的治疗。在此,我们提出了基于腮腺受累的修订版分类系统,除了管理指南外,还着重避免了基于胚芽层的分层。
{"title":"Comprehensive management and classification of first branchial cleft anomalies: An International Pediatric Otolaryngology Group (IPOG) consensus statement","authors":"","doi":"10.1016/j.ijporl.2024.112095","DOIUrl":"10.1016/j.ijporl.2024.112095","url":null,"abstract":"<div><h3>Objective</h3><p>First branchial cleft anomalies are rare congenital head and neck lesions. Literature pertaining to classification, work up and surgical treatment of these lesions is limited and, in some instances, contradictory. The goal of this work is to provide refinement of the classification system of these lesions and to provide guidance for clinicians to aid in the comprehensive management of children with first branchial cleft anomalies.</p></div><div><h3>Materials and methods</h3><p>Delphi method survey of expert opinion under the direction of the International Pediatric Otolaryngology Group (IPOG) was conducted to generate recommendations for the definition and management of first branchial cleft anomalies. The recommendations are the result of expert consensus and critical review of the literature.</p></div><div><h3>Results</h3><p>Consensus recommendations include evaluation and diagnostic considerations for children with first branchial cleft anomalies as well as recommendations for surgical management. The current Work classification system was reviewed, and modifications were made to it to provide a more cogent categorization of these lesions.</p></div><div><h3>Conclusion</h3><p>The mission of the International Pediatric Otolaryngology Group (IPOG) is to develop expertise-based recommendations based on review of the literature for the management of pediatric otolaryngologic disorders. These consensus recommendations are aimed at improving care of children presenting with first branchial cleft anomalies. Here we present a revised classification system based on parotid gland involvement, with a focus on avoiding stratification based on germ layer, in addition to guidelines for management.</p></div>","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142228899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Head and neck ice hockey injuries in children: an analysis of the NEISS database 儿童头颈部冰上曲棍球受伤情况:NEISS 数据库分析
IF 1.2 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-09-06 DOI: 10.1016/j.ijporl.2024.112093

Objective

Our objective was to describe non-concussion head and neck ice hockey injuries in children in the US.

Methods

This is a retrospective cohort study using data from the NEISS database. The NEISS database was reviewed from 2010 to 2021 for injuries in the head, neck, mouth, eye, and ear related to ice hockey in children 1–18 years old. Records where the only injury was a concussion or internal head injury were removed. Frequencies were calculated and chi-squared tests were performed.

Results

475 children were included, with mean age of 13.1 years old (95 % CI 12.7–13.4), and 426 (89.7 %) were male. Females were significantly younger with mean age 11.8 years versus 13.2 years for males (t = −2.4, df = 473, p = .018). 110 (23.2 %) injuries were related to hockey sticks, 92 (19.4 %) involved a fall, and 32 (6.7 %) were subsequent to body checking. 301 of the injuries (63.4 %) were lacerations, 71 (14.9 %) contusions or abrasions, and 26 (5.5 %) strains and sprains. The type of injury varied according to head and neck region (p < .001). 231 (82.8 %) of facial injuries, 16 (76.2 %) of ear injuries, and 33 (62.3 %) of oral injuries were lacerations. Eight (1.7 %) patients were admitted or observed overnight, while the rest were discharged home.

Conclusion

Female ice hockey players sustain injuries at younger ages than males, which may reflect the loss of older girls from the sport. In older boys, injury rates may reflect the loss of mandated full face protective shields.

目标我们的目标是描述美国儿童冰上曲棍球非脑震荡性头部和颈部损伤的情况。方法这是一项回顾性队列研究,使用的数据来自 NEISS 数据库。研究人员查阅了 2010 年至 2021 年期间 NEISS 数据库中与冰上曲棍球相关的 1-18 岁儿童头部、颈部、口腔、眼部和耳部受伤情况。删除了仅有脑震荡或头部内伤的记录。结果 475 名儿童的平均年龄为 13.1 岁(95 % CI 12.7-13.4),其中 426 名(89.7 %)为男性。女性明显更年轻,平均年龄为 11.8 岁,而男性为 13.2 岁(t = -2.4,df = 473,p = .018)。110起(23.2%)受伤与曲棍球杆有关,92起(19.4%)与摔倒有关,32起(6.7%)与身体碰撞有关。其中 301 例(63.4%)为撕裂伤,71 例(14.9%)为挫伤或擦伤,26 例(5.5%)为拉伤和扭伤。受伤类型因头颈部区域而异(p <.001)。231例(82.8%)面部受伤,16例(76.2%)耳部受伤,33例(62.3%)口腔受伤为撕裂伤。结论女性冰上曲棍球运动员受伤的年龄比男性小,这可能反映了年龄较大的女孩在这项运动中的流失。在年龄较大的男孩中,受伤率可能反映了强制性全脸保护罩的丧失。
{"title":"Head and neck ice hockey injuries in children: an analysis of the NEISS database","authors":"","doi":"10.1016/j.ijporl.2024.112093","DOIUrl":"10.1016/j.ijporl.2024.112093","url":null,"abstract":"<div><h3>Objective</h3><p>Our objective was to describe non-concussion head and neck ice hockey injuries in children in the US.</p></div><div><h3>Methods</h3><p>This is a retrospective cohort study using data from the NEISS database. The NEISS database was reviewed from 2010 to 2021 for injuries in the head, neck, mouth, eye, and ear related to ice hockey in children 1–18 years old. Records where the only injury was a concussion or internal head injury were removed. Frequencies were calculated and chi-squared tests were performed.</p></div><div><h3>Results</h3><p>475 children were included, with mean age of 13.1 years old (95 % CI 12.7–13.4), and 426 (89.7 %) were male. Females were significantly younger with mean age 11.8 years versus 13.2 years for males (t = −2.4, df = 473, <em>p</em> = .018). 110 (23.2 %) injuries were related to hockey sticks, 92 (19.4 %) involved a fall, and 32 (6.7 %) were subsequent to body checking. 301 of the injuries (63.4 %) were lacerations, 71 (14.9 %) contusions or abrasions, and 26 (5.5 %) strains and sprains. The type of injury varied according to head and neck region (<em>p</em> &lt; .001). 231 (82.8 %) of facial injuries, 16 (76.2 %) of ear injuries, and 33 (62.3 %) of oral injuries were lacerations. Eight (1.7 %) patients were admitted or observed overnight, while the rest were discharged home.</p></div><div><h3>Conclusion</h3><p>Female ice hockey players sustain injuries at younger ages than males, which may reflect the loss of older girls from the sport. In older boys, injury rates may reflect the loss of mandated full face protective shields.</p></div>","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142164801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors influencing auditory brainstem response changes in infants 影响婴儿听觉脑干反应变化的因素。
IF 1.2 4区 医学 Q3 OTORHINOLARYNGOLOGY Pub Date : 2024-09-05 DOI: 10.1016/j.ijporl.2024.112094

Background

To elucidate the factors influencing auditory brainstem response (ABR) threshold improvement in infants.

Methods

This retrospective study included 626 infants who underwent ABR at the our Health and Medical Center between 2016 and 2020. Preliminary assessment indicated that 352 infants had an ABR threshold ≥40 dBnHL in both ears. A second ABR examination was conducted 5 months after delivery. The participants were divided into the improved (improvement ≥20 dBnHL) and unchanged (improvement <20 dBnHL) groups. The associations between risk factors were evaluated. Furthermore, we measured and compared the latencies of waves I, III, and V between participants with normal hearing and those in the improved and unchanged groups.

Results

The improved and unchanged groups consisted of 185 and 167 participants, respectively. ABR deterioration occurred in one infant with unilateral congenital cytomegalovirus-associated hearing loss. Binary logistic regression analysis revealed that the presence of otitis media with effusion and Down syndrome were factors contributing to ABR threshold improvement. In the ABR waveform analysis, patients in the improved group who had otitis media with effusion exhibited prolonged latencies of waves I, III, and V. Conversely, patients in the unchanged group who had Down syndrome showed shortened I–V interval.

Conclusions

Half of the infants tested the second time showed improvement in ABR threshold. Children with congenital syndromes (such as Down syndrome) or otitis media with effusion should undergo a second ABR examination or other auditory assessments to ensure an accurate diagnosis of hearing loss.

背景:旨在阐明影响婴儿听觉脑干反应(ABR)阈值提高的因素:阐明影响婴儿听性脑干反应(ABR)阈值提高的因素:这项回顾性研究纳入了 2016 年至 2020 年期间在本医疗保健中心接受 ABR 的 626 名婴儿。初步评估显示,352 名婴儿的双耳 ABR 阈值≥40 dBnHL。第二次 ABR 检查在婴儿出生 5 个月后进行。参试者被分为听力改善组(听力改善≥20 dBnHL)和听力不变组(听力改善 结果):好转组和不变组分别有 185 名和 167 名参与者。一名患有单侧先天性巨细胞病毒相关性听力损失的婴儿的 ABR 出现恶化。二元逻辑回归分析表明,存在中耳炎伴渗出和唐氏综合症是导致 ABR 阈值改善的因素。在 ABR 波形分析中,改善组中患有中耳炎伴渗出液的患者表现出 I、III 和 V 波潜伏期延长,相反,未改善组中患有唐氏综合征的患者表现出 I-V 波间隔缩短:结论:在第二次测试中,半数婴儿的 ABR 阈值有所改善。患有先天性综合症(如唐氏综合症)或中耳炎伴流脓的儿童应进行第二次 ABR 检查或其他听力评估,以确保听力损失的诊断准确无误。
{"title":"Factors influencing auditory brainstem response changes in infants","authors":"","doi":"10.1016/j.ijporl.2024.112094","DOIUrl":"10.1016/j.ijporl.2024.112094","url":null,"abstract":"<div><h3>Background</h3><p>To elucidate the factors influencing auditory brainstem response (ABR) threshold improvement in infants.</p></div><div><h3>Methods</h3><p>This retrospective study included 626 infants who underwent ABR at the our Health and Medical Center between 2016 and 2020. Preliminary assessment indicated that 352 infants had an ABR threshold ≥40 dBnHL in both ears. A second ABR examination was conducted 5 months after delivery. The participants were divided into the improved (improvement ≥20 dBnHL) and unchanged (improvement &lt;20 dBnHL) groups. The associations between risk factors were evaluated. Furthermore, we measured and compared the latencies of waves I, III, and V between participants with normal hearing and those in the improved and unchanged groups.</p></div><div><h3>Results</h3><p>The improved and unchanged groups consisted of 185 and 167 participants, respectively. ABR deterioration occurred in one infant with unilateral congenital cytomegalovirus-associated hearing loss. Binary logistic regression analysis revealed that the presence of otitis media with effusion and Down syndrome were factors contributing to ABR threshold improvement. In the ABR waveform analysis, patients in the improved group who had otitis media with effusion exhibited prolonged latencies of waves I, III, and V. Conversely, patients in the unchanged group who had Down syndrome showed shortened I–V interval.</p></div><div><h3>Conclusions</h3><p>Half of the infants tested the second time showed improvement in ABR threshold. Children with congenital syndromes (such as Down syndrome) or otitis media with effusion should undergo a second ABR examination or other auditory assessments to ensure an accurate diagnosis of hearing loss.</p></div>","PeriodicalId":14388,"journal":{"name":"International journal of pediatric otorhinolaryngology","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0165587624002489/pdfft?md5=fab2d4ac671f46f9366bd8c8809861ce&pid=1-s2.0-S0165587624002489-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142145648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International journal of pediatric otorhinolaryngology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1